Bruggmann, P.; Blach, S.; Deltenre, P.; Fehr, J.; Kouyos, R. D.; Lavanchy, D.; Müllhaupt, B.; Rauch, A.; Razavi, H.; Schmid, P.; Semela, D.; Stöckle, M.; Negro, F. Hepatitis C Virus Dynamics Among Intravenous Drug Users Suggest That an Annual Treatment Uptake above 10% Would Eliminate the Disease by 2030. Swiss Med Wkly 2017, 147, w14543.